Management of severe community-acquired pneumonia of children in developing and developed countries

Thorax

Volumn 66, Issue 9, 2011, Pages 815-822

  Principi, Nicola ^a   Esposito, Susanna ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CHLORAMPHENICOL; CLARITHROMYCIN; CLOXACILLIN; DICLOXACILLIN; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; MACROLIDE; OXACILLIN; PENICILLIN G; PIPERACILLIN; PNEUMOCOCCUS VACCINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BREATHING EXERCISE; BREATHING RATE; BRONCHIOLITIS; CHILD; CHILD HOSPITALIZATION; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EFFUSION; EMPYEMA; FLUID THERAPY; HAEMOPHILUS INFLUENZAE; HEALTH SERVICE; HUMAN; INFLUENZA VIRUS; LUNG ABSCESS; OXYGEN SATURATION; OXYGEN THERAPY; PARAPNEUMONIC EFFUSION; PATHOGENESIS; PLEURA FLUID; PNEUMATOCELE; PREDICTIVE VALUE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; RISK REDUCTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; VACCINATION; VIRUS INFECTION;

EID: 80051891810     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.142604     Document Type: Review

References (122)

1. Ranganathan S.C., Sonnappa S. Pneumonia and other respiratory infections. Pediatr Clin North Am 2009;56:135-156
2. Chisti M.J., Tebruegge M., La Vincente S., et al. Pneumonia in severely malnourished children in developing countries-mortality risk, aetiology and validity of WHO clinical signs: A systematic review. Trop Med Int Health 2009;14:1173-1189
3. Atkinson M., Yanney M., Stephenson T., et al. Effective treatment strategies for paediatric community acquired pneumonia. Expert Opin Pharmacother 2007;8:1091-1101 (Pubitemid 46929302)
4. Rudan I., Boschi-Pinto C., Biloglav Z., et al. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 2008;86:408-416 (Pubitemid 351694322)
5. Bryce J., Boschi-Pinto C., Shibuya K., et al. WHO estimates of the causes of death in children. Lancet 2005;365:1147-1152 (Pubitemid 40417564)
6. MacIntyre C., MacInryre P., Cagney M. Community-based estimates of incidence of risk factors for childhood pneumonia in Western Sydney. Epidemiol Infect 2003;131:1091-1096 (Pubitemid 38195582)
7. British Thoracic Society of Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in childhood. Thorax 2002;57:i1-24.
8. Rudan I., El Arifeen S., Black R.E., et al. Childhood pneumonia and diarrhoea: Setting our priorities right. Lancet Infect Dis 2007;7:56-61. (Pubitemid 44917782)
9. Palafox M., Guiscafre H., Reyes H., et al. Diagnostic value of tachypnoea in pneumonia defined radiologically. Arch Dis Child 2000;82:41-45 (Pubitemid 30305730)
10. Cherian T., John T.J., Simoes E., et al. Evaluation of simple clinical signs for the diagnosis of lower respiratory tract infection. Lancet 1988;2:125-128
11. World Health Organization. Pocket Book of Hospital Care for Children. Guidelines for the Management of Common Illnesses with Limited Resources. WHO Press, 2005:72-81.
12. Tupasi T.E., Velmonte M.A., Sanvictores M.E., et al. Determinants of morbidity and mortality due to acute respiratory infections: Implications for interventions. J Infect Dis 1988;157:615-623 (Pubitemid 18093717)
13. Tupasi T.E., Lucero M.G., Magdangal D.M., et al. Etiology of acute lower respiratory infections in children in Alabang, Metro Manila. Rev Infect Dis 1990;12(Suppl 8): S929-S939
14. Hazir T., Qazi S., Nisar Y.B., et al. Assessment and management of children aged 1-59 months presenting with wheeze, fast breathing, and/or lower chest indrawing: Results of a multicentre descriptive study in Pakistan. Arch Dis Child 2004;89:1049-1054
15. Puumalainen T., Quiambao B., Abucejo-Ladesma E., et al. Clinical case review: A method to improve identification of true clinical and radiographic pneumonia in children meeting the World Health Organization definition for pneumonia. BMC Infect Dis 2008;8:95.
16. ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. Eur Respir J 1998;11:986-991
17. Mandell A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44:527-572
18. Clark J.E., Hammal D., Spemver D., et al. Children with pneumonia: How do they present and how are they managed? Arch Dis Child 2007;92:394-398 (Pubitemid 46698134)
19. Tan T.Q., Mason E.O. Jr, Wald E., et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 2002;110:1-6. (Pubitemid 34742634)
20. Michelow I.C., Olsen K., Lozano J., et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004;113:701-707 (Pubitemid 38437371)
21. Principi N., Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory tract infections. Lancet Infect Dis 2001;1:334-344 (Pubitemid 33586614)
22. Esposito S., Principi N. Emerging resistance to antibiotics against respiratory bacteria: Impact on therapy of community-acquired pneumonia in children. Drug Res Up 2002;5:73-87. (Pubitemid 35024270)
23. Grafakou O., Moustaki M., Tsolia M., et al. Can chest X-ray predict pneumonia severity? Pediatr Pulmonol 2004;38:465-469 (Pubitemid 39571768)
24. Key V.K., Araùjo-Neto C.A., Nascimento-Carvalho C.M. Severity of childhood community-acquired pneumonia and chest radiographic findings. Pediatr Pulmonol 2009;44:249-252
25. Finelli L., Fiore A., Dhara R., et al. Influenza-associated pediatric mortality in the United States: Increase of Staphylococcus aureus coinfection. Pediatrics 2008;122:805-811
26. Esposito S., Marchisio P., Principi N. The global state of influenza in children. Pediatr Infect Dis J 2008;27(Suppl 11):S149-S153
27. Shann F., Gratten M., Germer S., et al. Aetiology of pneumonia in children in Goroka Hospital, Papua New Guinea. Lancet 1984;2:537-541 (Pubitemid 14044456)
28. Chowell G., Bertozzi S.M., Colchero M.A., et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009;361:674-679
29. Perez-Padilla R., De la Rosa-Zamboni D., Ponce de Leon S., et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361:680-689
30. Lister P., Reynolds F., Parslow R., et al. Swine-origin influenza virus H1N1, seasonal influenza virus H1N1, and critical illness in children. Lancet 2009;374:605-607
31. Jansen A.G., Sanders E.A., Hoes A.W., et al. Influenza- and respiratory syncytial virus-associated mortality and hospitalizations. Eur Respir J 2007;30:1158-1166 (Pubitemid 351194764)
32. Falade A.G., Mulholland E.K., Adegbola R.A., et al. Bacterial isolates from blood and lung aspirate cultures in Gambian children with lobar pneumonia. Ann Trop Paediatr 1997;17:315-319 (Pubitemid 27511113)
33. Forgie I.M., O'Neill K.P., Lloyd-Evans N., et al. Etiology of acute lower respiratory tract infections in Gambian children. II. Acute lower respiratory tract infection in children ages one to nine years presenting at the hospital. Pediatr Infect Dis J 1991;10:42-47
34. McCracken G.H. Jr. Diagnosis and management of pneumonia in children. Pediatr Infect Dis J 2000;19:924-928
35. Vuori-Holopainen E., Salo E., Saxén H., et al. Etiologic diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis 2002;34:583-590 (Pubitemid 34165319)
36. Mimica I., Donoso E., Howard J.E., et al. Lung puncture in the etiological diagnosis of pneumonia: A study of 543 infants and children. Am J Dis Child 1971;122:278-282
37. Klein J.O. Diagnostic lung puncture in the pneumonia of infants and children. Pediatrics 1969;44:486-492
38. Esposito S., Bosis S., Cavagna R., et al. Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community-acquired pneumonia. Clin Infect Dis 2002;35:1345-1352 (Pubitemid 35448962)
39. Gessner B.D., Sutanto A., Linehan M., et al. Incidence of vaccine-preventable Haemophilus influenzae type B pneumonia and meningitis in Indonesian children: Hamlet-randomised vaccine-probe trial. Lancet 2005;365:43-52. (Pubitemid 40082145)
40. Watt J.P., Wolfson L.J., O'Brien K.L., et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: Global estimates. Lancet 2009;374:903-911
41. Grijalva C.G., Nuorti J.P., Arbogast P.G. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: A time-series analysis. Lancet 2007;369:1179-1186 (Pubitemid 46527876)
42. O'Brien K.L., Wolfson L.J., Watt J.P., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: Global estimates. Lancet 2009;374:893-902.
43. Van der Poll T., Opal S.M. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009;374:1543-1556
44. Chiang W.C., Teoh O.H., Chong C.Y., et al. Epidemiological, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore. Respirology 2007;12:254-261 (Pubitemid 46239400)
45. Wexler I.D., Knoll S., Picard E., et al. Clinical characteristics and outcome of complicated pneumococcal pneumonia in a pediatric population. Pediatr Pulmonol 2006;41:726-734 (Pubitemid 44157355)
46. Cevey-Macherel M., Galetto-Lacour A., Gervaix A., et al. Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr 2009;168:1429-1436
47. Hausdorff W.P., Feikin D.R., Klugman K.P. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005;5:83-93. (Pubitemid 40174779)
48. Byington C.L., Korgenski K., Daly J., et al. Impact of pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 2006;25:250-254 (Pubitemid 43379067)
49. Fletcher M., Leeming J., Cartwright K., et al. Childhood empyema: Limited potential impact of 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2006;25:559-560 (Pubitemid 43863370)
50. De Schutter I.D., Malfroot A., Piérard D., et al. Pneumococcal serogroups and serotypes in severe pneumococcal pneumonia in Belgian children: Theoretical coverage of the 7-valent and 9-valent pneumococcal conjugate vaccine. Pediatr Pulmonol 2006;41:765-770 (Pubitemid 44157361)
51. Bender J.M., Ampofo K., Korgenski K., et al. Pneumococcal necrotizing pneumonia in Utah: Does serotype matter? Clin Infect Dis 2008;46:1346-1352 (Pubitemid 351589931)
52. Arifeen S.E., Hoque D.M., Akter T., et al. Effect of the integrated management of childhood illness strategy on childhood mortality and nutrition in a rural area of Bangladesh: A cluster randomised trial. Lancet 2009;374:393-403.
53. Subhi R., Adamson M., Campbell H., et al. The prevalence of hypoxaemia among ill children in developing countries: A systematic review. Lancet Infect Dis 2009;9:219-227
54. Grant G.B., Campbell H., Dowell S.F., et al. Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect Dis 2009;9:185-196
55. Rojas M.X., Granados Rugeles C. Oral antibiotics versus parenteral antibiotics for severe pneumonia in children. Cochrane Database Syst Rev 2006;(2):CD004979.
56. Campbell H., Byass P., Forgie I.M., et al. Trial of co-trimoxazole versus procaine penicillin with ampicillin in treatment of community-acquired pneumonia in young Gambian children. Lancet 1988;2:1182-1184 (Pubitemid 18267012)
57. Addo-Yobo E., Chisaka N., Hassan M., et al. Oral amoxicillin versus injectable oenicillin for severe pneumonia in children aged 3 to 50 months: A randomized multicentre equivalency study. Lancet 2004;364:1141-1148 (Pubitemid 39296601)
58. Atkinson M., Lakhanpaul M., Smyth A., et al. Comparison of oral amoxicillin and intravenous benzyl penicillin for community-acquired pneumonia in children (PIVOT trial): A multicentre pragmatic randomized controlled equivalence trial. Thorax 2007;62:1102-1106 (Pubitemid 350206206)
59. Hazir T., Fox L.M., Nisar Y.B., et al. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: A randomized equivalency trial. Lancet 2008;371:49-56.
60. Mamtani M., Patel A., Hibberd P.L., et al. A clinical tool to predict failed response to therapy in children with severe pneumonia. Pediatr Pulmonol 2009;44:379-386
61. Tiewsoh K., Lodha R., Pandey R.M., et al. Factors determining the outcome of children hospitalized with severe pneumonia. BMC Pediatr 2009;9:15.
62. Djelantik I.G., Gessner B.D., Sutanto A., et al. Case fatality proportion and predictive factors for mortality among children hospitalized for severe pneumonia in a rural developing country setting. J Trop Pediatr 2003;49:327-332 (Pubitemid 37540956)
63. Onyango F.E., Steinhoff M.C., Wafula E.M., et al. Hypoxaemia in young Kenyan children with acute lower respiratory infection. BMJ 1993;306:612-615 (Pubitemid 23065822)
64. Smyth A., Charty H., Hart C.A. Clinical predictors of hypoxaemia in children with pneumonia. Ann Trop Paediatr 1988;18:31-40.
65. Usen S., Weber M., Mulholland K., et al. Clinical predictors of hypoxaemia in Gambian children with acute lower respiratory tract infection: Prospective cohort study. BMJ 1999;318:86-91. (Pubitemid 29191714)
66. Fu L.Y., Ruthazer R., Wilson I., et al. Brief hospitalization and pulse oximetry for predicting amoxicillin treatment failure in children with severe pneumonia. Pediatrics 2006;118:e1822-30.
67. Patel A., Mamtani N., Hibberd P.M., et al. Value of chest radiography in predicting treatment response in children aged 3-59 months with severe pneumonia. Int J Tuberc Lung Dis 2008;12:1320-1326
68. McIntosh K. Community acquired pneumonia in children. N Engl J Med 2002;346:429-437
69. Jadavji T., Law B., Lebel M., et al. A practical guide for the diagnosis and treatment of pediatric pneumonia. Can Med Assoc J 1997;156:S703-S711 (Pubitemid 27117244)
70. Hale K., Isaacs D. Antibiotics in childhood pneumonia. Paediatr Respir Rev 2006;7:145-151 (Pubitemid 43812271)
71. Finch R. Bacterial resistance: The clinical challenge. Clin Microbiol Infect 2002;8(Suppl 3):21-32.
72. Felmingham D., Feldman C., Hrynicwicz W., et al. Surveillance of resistance of bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect 2002;8(Suppl 2):12-42. (Pubitemid 35203498)
73. Feldman C. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med 2004;143:269-283 (Pubitemid 38586492)
74. Tan R.Q., Mason E.O. Jr, Barson W.J., et al. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics 1998;102:1369-1375 (Pubitemid 28550828)
75. Choi E.H., Lee H.J. Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children. Clin Infect Dis 1998;26:1346-1354
76. Friedland I.R. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J 1995;14:885-890
77. Cardoso M.R., Nascimento-Carvalho C.M., Ferrero F., et al. Penicillin-resistant pneumococcus and risk of treatment failure in pneumonia. Arch Dis Child 2008;93:221-225 (Pubitemid 352025494)
78. Nascimento-Carvalho C.M., Cardoso M.R., Brandileone M.C., et al. Pencillin/ampicillin efficacy among children with severe pneumonia due to penicillin resistant pneumococcus (MIC=4 μg/mL). J Med Microbiol 2009;58:1390-1392
79. Craig W.A. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-12. (Pubitemid 28068148)
80. Bryan C.S., Talwani E., Stinson M.S. Penicillin dosing for pneumococcal pneumonia. Chest 1997;112:1657-1664 (Pubitemid 28007774)
81. Pihlajamaki M., Kotilainen P., Kaurila T., et al. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis 2001;33:483-488 (Pubitemid 32709580)
82. Lonks J.R., Garau J., Gomez L., et al. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis 2002;35:556-564
83. Hausdorff W.P. The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease. Vaccine 2007;25:2406-2412 (Pubitemid 46366120)
84. Hendrickson D.J., Blumberg D.A., Joad J.P., et al. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2008;27:1030-1032
85. Gupta R., Crowley S. Increasing paediatric empyema admissions. Thorax 2006;61:179-181
86. Hilliard T.N., Henderson A.J., Langton Hewer S.C. Management of parapneumonic effusion and empyema. Arch Dis Child 2003;88:915-917 (Pubitemid 37194051)
87. Hicks L.A., Harrison L.H., Flannery B., et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV-7) serotypes in the United State during the era of widespread PCV-7 vaccination, 1998-2004. J Infect Dis 2007;196:1346-1354 (Pubitemid 351412007)
88. Choi E.H., Kim S.H., Eun B.W., et al. Streptococcus pneumoniae serotype 19 A in children, South Korea. Emerg Infect Dis 2008;14:275-281
89. Eltringham G., Kearns A., Freeman R., et al. Culture-negative childhood empyema is usually due to penicillin sensitive Streptococcus pneumoniae capsular serotype 1. J Clin Microbiol 2003;41:521-522 (Pubitemid 36098641)
90. Proesmans M., De Boeck K. Clinical practice: Treatment of childhood empyema. Eur J Pediatr 2009;168:639-645
91. Mitri R.K., Brown S.D., Zurakowski D., et al. Outcomes of primary image-guided drainage of parapneumonic effusion in children. Pediatrics 2002;110:37-43.
92. Balfour-Lynn I.M., Abrahamson E., Cihen G., et al. BTS guidelines for the management of pleural infection in children. Thorax 2005;60(Suppl 1):i1-21.
93. Maskell N.A., Davies C.W., Nunn A.J., et al. First multicenter intrapleural sepsis trial (MISTI) group. UK controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005;352:865-874 (Pubitemid 40300295)
94. Yao C.T., Wu J.M., Liu C.C., et al. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children. Chest 2004;125:566-571
95. Aydigan N., Aydigan A., Ozcan A., et al. Intrapleural streptokinase treatment in children with empyema. Eur J Pediatr 2008;167:739-744 (Pubitemid 351733506)
96. Avansino J.R., Goldman B., Sawin R.S., et al. Primary operative versus nonoperative therapy for pediatric empyema: A meta-analysis. Pediatrics 2005;115:1652-1659 (Pubitemid 43843176)
97. Sonnappa S., Cohen G., Owens C.M., et al. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med 2006;174:221-227 (Pubitemid 44015396)
98. Kishk Y.T., Abou-Elmaqd A., Abdel-Wahab A.M. Identification of cardiovascular abnormalities in children with empyema thoracis by two-dimensional and Doppler echocardiography. Chest 1993;104:405-410 (Pubitemid 23229507)
99. Roberts J.E., Bezack B.J., Winger D.I., et al. Association between parapneumonic effusion and pericardial effusion in a pediatric cohort. Pediatrics 2008;122:e1231-e1235
100. Imamoǧlu M., Çay A, KoŞucu P, et al. Pneumatoceles in postpneumonic empyema: An algorithmic approach. J Pediatr Surg 2005;40:111-117
101. Puligandla P.S., Laberge J.M. Respiratory infections: Pneumonia, lung abscess, and empyema. Semin Pediatr Surg 2008;17:42-52. (Pubitemid 350297998)
102. Patradoon-Ho P., Fitzgerlad D.A. Lung abscess in children. Paediatr Respir Rev 2007;8:77-84. (Pubitemid 46523783)
103. Al-Saleh S., Grasemann H., Cox P. Necrotizing pneumonia complicated by early and late pneumatoceles. Can Respir J 2008;15:129-132 (Pubitemid 351877368)
104. Yen C.C., Tang R.B., Chen S.J., et al. Pediatric lung abscess: A retrospective review of 23 cases. J Microbiol Immunol Infect 2004;37:45-49
105. May M.L., Robson J. Microbiological diagnosis procedures in respiratory infections: Suppurative lung disease. Paediatr Respir Rev 2007;8:185-193
106. Hidron A.I., Low C.E., Honig E.G., et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotizing community-onset pneumonia. Lancet Infect Dis 2009;9:384-392
107. Thomas B., Pugalenthi A., Chilvers M. Pleuropulmonary complications of PVL-positive Staphylococcus aureus infection in children. Acta Paediatr 2009;98:1372-1375
108. Hsieh Y.C., Hsiao C.H., Tsao P.N., et al. Necrotizing pneumococcal pneumonia in children: The role of pulmonary gangrene. Pediatr Pulmonol 2006;41:623-629
109. Kalaskar A.S., Heresi G.P., Wanger A., et al. Severe necrotizing pneumonia in children, Houston, Texas, USA. Emerg Infect Dis 2009;15:1696-1698
110. Hogan M.J., Coley B.D. Interventional radiology treatment of empyema and lung abscesses. Paediatr Respir Rev 2008;9:77-84.
111. Principi N., Esposito S. Paediatric community-acquired pneumonia: Current concepts in pharmacological control. Expert Opin Pharmacother 2003;4:761-777 (Pubitemid 36622206)
112. Ramphul N., Eastham K.M., Freeman R., et al. Cavitatory lung disease complicating empyema in children. Pediatr Pulmonol 2006;41:750-753 (Pubitemid 44157358)
113. Yunus M. CT guided transthoracic catheter drainage of intrapulmonary abscess. J Pak Med Assoc 2009;59:703-709
114. Sporik R. Why block a small hole? The adverse effect of nasogastric tubes. Arch Dis Child 1994;71:393-394 (Pubitemid 24349843)
115. Dhawan A., Narang A., Singhi S. Hyponatraemia and the inappropriate ADH syndrome in pneumonia. Ann Trop Paediatr 1992;12:455-462 (Pubitemid 23019227)
116. Haviv M., Haver E., Lichtstein D., et al. Atrial natriuretic peptide in children with pneumonia. Pediatr Pulmonol 2005;40:306-309 (Pubitemid 41437607)
117. Balachandran A., Shivbalan S., Thangavelu S. Chest physiotherapy in pediatric practice. Indian Pediatr 2005;42:559-568 (Pubitemid 40896528)
118. Wallis C., Prasad A. Who needs physiotherapy? Moving from anecdote to evidence. Arch Dis Child 1999;80:393-397 (Pubitemid 29164770)
119. Britton S., Bejstedt M., Vedin L. Chest physiotherapy in primary pneumonia. BMJ 1985;290:1703-1704 (Pubitemid 15057038)
120. Levine A. Chest physical therapy for children with pneumonia. J Am Ostheopath Assoc 1978;78:22-25
121. Stapleton T. Chest physiotherapy in primary pneumonia. BMJ 1985;291:143.
122. Paludo C., Zhang L., Lincho C.S., et al. Chest physical therapy for children hospitalized with acute pneumonia: A randomized controlled trial. Thorax 2007;63:791-794